ARTICLE | Financial News
BerGenBio completes IPO
April 14, 2017 4:31 PM UTC
On April 6, cancer company BerGenBio ASA (OSE:BGBIO) raised NOK400 million ($46.6 million) through the sale of 16 million shares at NOK25 in an IPO underwritten by ABG Sundal Collier, Arctic Securiti...
BCIQ Company Profiles